Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 22263-22264 [2018-10224]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 93 / Monday, May 14, 2018 / Notices
2. Legacy BancShares, Inc.,
Springdale, Arkansas; to merge with
Gravett Bancshares, Inc., Gravette,
Arkansas, and thereby indirectly acquire
Bank of Gravett, Gravette, Arkansas.
Board of Governors of the Federal Reserve
System, May 9, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018–10198 Filed 5–11–18; 8:45 am]
BILLING CODE P
Dr.
Hana Pohl, Division of Toxicology and
Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329. Telephone: 770.488.3355.
Email: hrp1@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[Docket No. ATSDR–2018–0004]
Availability of Draft Interaction Profile
for Mixtures of Insecticides:
Pyrethroids, Organophosphorus
Compounds, and Carbamates
Agency for Toxic substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability; request
for comments.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), within the Department of
Health and Human Services (HHS)
announces the availability of the Draft
Interaction Profile for Mixtures of
Insecticides: Pyrethroids,
Organophosphorus Compounds, and
Carbamates for review and comment.
This interaction profile evaluates a
mixture of chemicals often found in
human blood, adipose tissue, and breast
milk. The purpose of this interaction
profile is to investigate the possible joint
actions of these chemicals on endocrine,
developmental, and neurobehavioral
endpoints in humans. This interaction
profile has undergone external peerreview and review by ATSDR’s
Interagency Workgroup on Mixtures.
ATSDR remains committed to
providing a public comment period for
these documents as a means to best
serve public health and the public.
DATES: Comments must be submitted by
August 13, 2018.
ADDRESSES: You may submit comments,
identified by docket number ATSDR–
2018–0004, by any of the following
methods:
• Internet: Access the Federal
eRulemaking Portal at
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Division of Toxicology and
Human Health Sciences, Agency for
amozie on DSK3GDR082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:02 May 11, 2018
Jkt 244001
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329, Attn: Docket ATSDR–2018–
0004.
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change. This means that no confidential
business information or other
confidential information should be
submitted in response to this notice.
ATSDR
develops interaction profiles for
hazardous substances found at the
National Priorities List (NPL) sites
under Sections 104(i)(3) and (5) of the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA), as amended by
the Superfund Amendments and
Reauthorization Act of 1986 (SARA).
This law requires that ATSDR assess
whether or not adequate information on
health effects is available for priority
hazardous substances. Where such
information is not available or under
development, ATSDR shall, in
cooperation with the National
Toxicology Program, initiate a research
program to determine these health
effects. The Act further directs that,
where feasible, ATSDR shall develop
methods to determine the health effects
of these priority hazardous substances
in combination with other substances
commonly found with them.
To carry out these legislative
mandates, ATSDR has created a
chemical mixtures program and
developed a document, ‘‘Framework for
Assessing Health Impacts of Multiple
Chemicals and Other Stressors,’’ that
outlines the latest methods for mixtures
health assessment. The Framework
document is available online at https://
www.atsdr.cdc.gov/interactionprofiles/
ipga.html. In addition, a series of
documents, called ‘‘interaction
profiles,’’ is developed for certain
priority mixtures that are of special
concern to ATSDR. To recommend
approaches for the exposure-based
assessment of the potential hazard to
public health, an interaction profile
evaluates data on the toxicology of the
whole priority mixture, if available, and
on the joint toxic action of the
chemicals in the mixture.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
22263
Availability
The Draft Interaction Profile for
Mixtures of Insecticides: Pyrethroids,
Organophosphorus Compounds, and
Carbamates is available online at
https://www.atsdr.cdc.gov/
interactionprofiles/index.asp and at
www.regulations.gov, Docket No.
ATSDR–2018–0004.
Pamela I. Protzel Berman,
Director, Office of Policy, Planning and
Partnerships, Agency for Toxic Substances
and Disease Registry.
[FR Doc. 2018–10204 Filed 5–11–18; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This
meeting is open to the public limited
only by the space and ports available.
The meeting room accommodates 70
participants and there will be 125 ports
available. Due to the limited
accommodations by phone ports and
room size, we are encouraging the
public to please register using the link
provided: Register Here. There will be
public comment periods from 11:10
a.m.–11:40 a.m., on June 19, 2018, and
from 11:30 a.m.–11:45 a.m., on June 20,
2018. All public comments will be
limited to two-minutes per speaker.
DATES: The meeting will be held on June
19, 2018, 8:30 a.m.–5:15 p.m., EDT and
June 20, 2018, 8:30 a.m.–12:15 p.m.,
EDT.
ADDRESSES: Center for Disease Control
and Prevention, Chamblee Campus,
4770 Buford Highway, Building 107,
Conference Room 1–A/B, Atlanta,
Georgia 30341 and via Teleconference:
Dial-In Number: 1–888–769–9404,
Participant Code: 5536840. (U.S. &
Canada Participants) 1–210–234–0065,
Participant Code: 5536840 (International
Participants).
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
SUMMARY:
E:\FR\FM\14MYN1.SGM
14MYN1
amozie on DSK3GDR082PROD with NOTICES
22264
Federal Register / Vol. 83, No. 93 / Monday, May 14, 2018 / Notices
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios, and (5)
review of program proposals.
Matters To Be Considered: Day One:
The agenda will include discussions on
Methodologies for Estimating Rates of
Opioid Prescribing; a request and BSC
vote to establish a workgroup to
estimate, or provide reference points for,
opioid prescribing for acute and chronic
pain; the Center’s focus on science
matters to include research strategies
needed to guide the Center’s focus on
reducing opioid overdose; and CDC and
NIH research to reduce opioid overdose.
Public comments on the formation of
the Opioid Prescribing Estimates
workgroup must be made during the
comment period on June 19, 2018, 11:10
VerDate Sep<11>2014
18:34 May 11, 2018
Jkt 244001
a.m.–11:40 a.m. to be considered before
the BSC vote. Day Two: The agenda will
include discussions on reducing youth
violence through CDC’s National
Centers of Excellence in Youth Violence
Prevention, and discuss improvements
to Web-based Injury Statistics Query
and Reporting System (WISQARS) data
visualization. Agenda items are subject
to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2018–10224 Filed 5–11–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2018–0046, NIOSH–
313]
Occupational Robotics Research
Prioritization
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for information and
comment.
AGENCY:
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention has recently established the
Center for Occupational Robotics
Research. NIOSH is requesting
information to guide the prioritization
of research to be undertaken by the
Center. NIOSH is seeking input on
priority gaps in knowledge on the safety
and health of humans working with
robotics technology, with an emphasis
on worker safety and health research
which is unlikely to be completed by
other federal agencies, academia, and
the private sector.
SUMMARY:
Table of Contents
• DATES:
• ADDRESSES:
• FOR FURTHER INFORMATION
CONTACT:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
•
•
•
•
SUPPLEMENTARY INFORMATION:
BACKGROUND:
INFORMATION NEEDS:
REFERENCES:
Electronic or written comments
must be received by July 13, 2018.
ADDRESSES: You may submit comments,
identified by CDC–2018–0046 and
docket number NIOSH–313, by any of
the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2018–0046; NIOSH–313]. All
relevant comments received will be
posted without change to
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov. All information
received in response to this notice will
also be available for public examination
and copying at the NIOSH Docket
Office, 1150 Tusculum Avenue, Room
155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT:
Hongwei Hsiao, Ph.D., NIOSH Division
of Safety Research, 1095 Willowdale
Road, Morgantown, WV 26505, 304–
285–5910 (not a toll-free number),
hhsiao@cdc.gov.
SUPPLEMENTARY INFORMATION: Industrial
robots have been a significant part of the
workplace for decades. Within the last
decade, there have been dramatic
advances in robotics technology which
have changed the types of work
performed by robots and how robots
interact with human workers. Whereas
traditional industrial robots operate in
cages or cells that are off-limits to
human workers, newer types of robots
are designed to work in collaboration
with and in shared spaces with human
workers. In collaborative operation,
robots work in close proximity to
humans and can potentially come into
contact depending on the collaborative
functionality implemented into the
robot system. The use of robots has been
rapidly increasing in many industrial
sectors, including the manufacturing,
healthcare, mining, and construction
sectors. The International Federation of
Robotics reported that the worldwide
growth of industrial robots will be at
least 15% annually from 2018 to 2020,
and the stock of operational industrial
robots will exceed 3 million units by the
end of 2020 [IFR 2017]. Within the
DATES:
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 83, Number 93 (Monday, May 14, 2018)]
[Notices]
[Pages 22263-22264]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10224]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
meeting is open to the public limited only by the space and ports
available. The meeting room accommodates 70 participants and there will
be 125 ports available. Due to the limited accommodations by phone
ports and room size, we are encouraging the public to please register
using the link provided: Register Here. There will be public comment
periods from 11:10 a.m.-11:40 a.m., on June 19, 2018, and from 11:30
a.m.-11:45 a.m., on June 20, 2018. All public comments will be limited
to two-minutes per speaker.
DATES: The meeting will be held on June 19, 2018, 8:30 a.m.-5:15 p.m.,
EDT and June 20, 2018, 8:30 a.m.-12:15 p.m., EDT.
ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus,
4770 Buford Highway, Building 107, Conference Room 1-A/B, Atlanta,
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-769-9404,
Participant Code: 5536840. (U.S. & Canada Participants) 1-210-234-0065,
Participant Code: 5536840 (International Participants).
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
[[Page 22264]]
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430, Email address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios, and (5) review of program proposals.
Matters To Be Considered: Day One: The agenda will include
discussions on Methodologies for Estimating Rates of Opioid
Prescribing; a request and BSC vote to establish a workgroup to
estimate, or provide reference points for, opioid prescribing for acute
and chronic pain; the Center's focus on science matters to include
research strategies needed to guide the Center's focus on reducing
opioid overdose; and CDC and NIH research to reduce opioid overdose.
Public comments on the formation of the Opioid Prescribing Estimates
workgroup must be made during the comment period on June 19, 2018,
11:10 a.m.-11:40 a.m. to be considered before the BSC vote. Day Two:
The agenda will include discussions on reducing youth violence through
CDC's National Centers of Excellence in Youth Violence Prevention, and
discuss improvements to Web-based Injury Statistics Query and Reporting
System (WISQARS) data visualization. Agenda items are subject to change
as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2018-10224 Filed 5-11-18; 8:45 am]
BILLING CODE 4163-18-P
